We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$5.05B
AUM Growth
+$394M
Cap. Flow
+$22.6M
Cap. Flow %
0.45%
Top 10 Hldgs %
24.03%
Holding
215
New
8
Increased
74
Reduced
105
Closed
7

Top Buys

Rank Stock Value
1
AES icon
AES
AES
+$43.4M
2
NVS icon
Novartis
NVS
+$14.1M
3
CPAY icon
Corpay
CPAY
+$12.8M
4
VMC icon
Vulcan Materials
VMC
+$11.5M
5
BR icon
Broadridge
BR
+$9.9M

Top Sells

Rank Stock Value
1
MAS icon
Masco
MAS
+$48.1M
2
NVDA icon
NVIDIA
NVDA
+$39.5M
3
BBWI icon
Bath & Body Works
BBWI
+$18.8M
4
APTV icon
Aptiv
APTV
+$12.9M
5
CSCO icon
Cisco
CSCO
+$10.8M

Sector Composition

Rank Sector Weight
1 Financials 19.96%
2 Technology 18.71%
3 Healthcare 15.59%
4 Industrials 10.32%
5 Consumer Discretionary 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
D icon
176
Dominion Energy
D
$59.3B
$294K 0.01%
+3,725
New +$293K
HSY icon
177
Hershey
HSY
$36.6B
$294K 0.01%
2,054
-94
-4% -$13.3K
TXN icon
178
Texas Instruments
TXN
$261B
$292K 0.01%
2,044
-221
-10% -$30K
HUBB icon
179
Hubbell
HUBB
$27.2B
$281K 0.01%
2,050
– –
CSX icon
180
CSX Corp
CSX
$93.1B
$275K 0.01%
10,638
– –
EPD icon
181
Enterprise Products Partners
EPD
$81.7B
$275K 0.01%
17,401
-375
-2% -$6.57K
BN icon
182
Brookfield
BN
$108B
$273K 0.01%
15,415
– –
GILD icon
183
Gilead Sciences
GILD
$165B
$273K 0.01%
4,317
-350
-7% -$24.3K
NVO
184
Novo Nordisk
NVO
$209B
$268K 0.01%
7,708
-370
-5% -$12.3K
BAX icon
185
Baxter International
BAX
$14.2B
$267K 0.01%
3,325
– –
PAYX icon
186
Paychex
PAYX
$42.7B
$260K 0.01%
3,259
-600
-16% -$45.1K
BF.B icon
187
Brown-Forman Class B
BF.B
$13.1B
$254K 0.01%
3,375
– –
BLK icon
188
Blackrock
BLK
$176B
$247K ﹤0.01%
438
-50
-10% -$28.5K
SHOP icon
189
Shopify
SHOP
$195B
$232K ﹤0.01%
+2,270
New +$226K
OTIS icon
190
Otis Worldwide
OTIS
$28.2B
$222K ﹤0.01%
3,554
-878
-20% -$53.7K
CRM icon
191
Salesforce
CRM
$158B
$215K ﹤0.01%
+856
New +$187K
MANH icon
192
Manhattan Associates
MANH
$11.4B
$214K ﹤0.01%
2,240
-2,205
-50% -$209K
AVB icon
193
AvalonBay Communities
AVB
$26.8B
$213K ﹤0.01%
1,428
-135
-9% -$20.7K
TJX icon
194
TJX Companies
TJX
$178B
$207K ﹤0.01%
+3,719
New +$200K
CLX icon
195
Clorox
CLX
$12.7B
$206K ﹤0.01%
980
-75
-7% -$16.7K
MTCH icon
196
Match Group
MTCH
$8.55B
$206K ﹤0.01%
+1,863
New +$197K
PGR icon
197
Progressive
PGR
$125B
$200K ﹤0.01%
+2,117
New +$190K
PNC icon
198
PNC Financial Services
PNC
$101B
$200K ﹤0.01%
1,820
-219
-11% -$23.6K
SDC
199
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$187K ﹤0.01%
15,997
– –
FULT icon
200
Fulton Financial
FULT
$4.64B
$142K ﹤0.01%
15,180
– –
5 6 7
8
9

Similar funds

GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
KWM
Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Douglas Lane & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Douglas Lane & Associates held 215 positions worth $5.05B, up 8.5% from $4.66B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Douglas Lane & Associates's Q3 2020 filing shows 8 new, 74 increased, 105 reduced and 7 closed positions. Its largest new stake was AES: 2,595,377 shares worth $47M. The largest sale was Masco, an estimated $48.1M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • Douglas Lane & Associates's largest Q3 2020 buy was AES: 2,595,377 shares worth $47M.
  • Douglas Lane & Associates added most to Novartis in Q3 2020, an estimated $14.1M increase.
  • Douglas Lane & Associates's biggest Q3 2020 reduction was Masco, cutting an estimated $48.1M.
  • Douglas Lane & Associates fully exited Dentsply Sirona in Q3 2020, selling an estimated $1.98M.
  • Douglas Lane & Associates's ten largest holdings make up 24% of its $5.05B portfolio in Q3 2020.
  • Douglas Lane & Associates opened 8 new positions and closed 7 in Q3 2020.
  • Douglas Lane & Associates's portfolio value rose 8.5% quarter-over-quarter to $5.05B.

Based on Douglas Lane & Associates's 13F filing for Q3 2020, filed 19 Oct 2020.